Business Overview

·       ACON Pharmaceuticals Inc. is a privately held corporation located in New Jersey, USA. As a dynamic pharmaceutical company in a vibrant life science research region, ACON Pharma leverages the expertise and experience of highly skilled, multi-disciplinary workforce to innovate pharmaceutical product discovery and development.

 ACON Pharma is a specialty pharmaceutical company and focuses on siRNA and mRNA nanoparticle delivery, long-active microsphere product development with its captive drug delivery and technology platforms.

Treatment or Platform 

ACON focus on the treatment of pulmonary fibrosis by siRNA lipid nanoparticles (LNP) inhalation and lung-targeting IV injection; the treatment of hemophilia by GalNAC siRNA delivery system; the treatment of schizophrenia by long-acting microsphere platform.

Target Market Size 

Pulmonary fibrosis has estimated 4.3 billion dollars market size; Schizophrenia has estimated 9 billion dollar market size; Hemophilia has estimated 14.2 billion dollars market size;

Has raised $1M already. Now it’s time to raise additional $5M as an early stage startup.

Reach out to us for Business Plan.